Cargando…
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Many clinical trials have been carried out or are in progress to assess the therapeutic potential of dendritic-cell- (DC-) based vaccines on cancer patients, and recently the first DC-based vaccine for human cancer was approved by the FDA. Herewith, we describe the general characteristics of DCs and...
Autores principales: | Benencia, Fabian, Sprague, Leslee, McGinty, John, Pate, Michelle, Muccioli, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312387/ https://www.ncbi.nlm.nih.gov/pubmed/22505809 http://dx.doi.org/10.1155/2012/425476 |
Ejemplares similares
-
The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells
por: Sprague, Leslee, et al.
Publicado: (2011) -
Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012) -
Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
por: Muccioli, Maria, et al.
Publicado: (2011) -
Perspectives on Reprograming Cancer-Associated Dendritic Cells for Anti-Tumor Therapies
por: Benencia, Fabian, et al.
Publicado: (2014) -
Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
por: Benencia, Fabian, et al.
Publicado: (2008)